<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, we identified α-Cyperone as a fungicidal antifungal agent that can synergize with the activity of a fluconazole antifungal drug that can be used in combination antifungal therapy. While α-Cyperone inhibits drug-resistant fungal pathogens, it appears to have no effect on bacteria. Furthermore, α-Cyperone contains a novel property of inhibiting capsule synthesis in 
 <italic>Cryp. neoformans</italic>, the human fungal meningitis pathogen.
</p>
